IGF-1 Long R3 1mg – Advanced Pure Peptide Research Compound

Overview of IGF-1 Long R3 1mg

IGF-1 Long R3 1mg, also known as IGF-1 LR3 or Long Arginine 3 IGF-1, is a synthetic analogue of insulin-like growth factor 1 (IGF-1). It is a specialized research compound studied in laboratory settings to investigate growth-factor signalling, molecular interactions and cellular processes.

For researchers exploring advanced peptide science, IGF-1 Long R3 represents an interesting subject for studying the structural modifications of naturally occurring growth factors. Its modified amino acid sequence distinguishes it from native IGF-1 and makes it relevant to specific biochemical research investigations.

This product information is intended exclusively for qualified laboratory research audiences. IGF-1 LR3 is not an FDA-approved medicine and must not be used for human consumption, injection, veterinary applications or self-administration.

What Is IGF-1 LR3?

IGF-1 LR3 is a modified form of insulin-like growth factor 1. Its molecular structure includes an arginine substitution at position three and an additional 13-amino-acid extension.

These structural modifications influence how the molecule interacts with IGF-binding proteins. Consequently, IGF-1 LR3 has attracted scientific interest in studies examining growth-factor activity and cellular signalling pathways.

The compound is commonly identified by several names:

• IGF-1 Long R3
• IGF-1 LR3
• Long Arg3 IGF-1
• Long R3 IGF-I
• Long Arginine 3 IGF-1

Understanding these alternative names can help researchers locate relevant scientific literature and technical reference materials.

IGF-1 Long R3 1mg – Technical Specifications

The following technical information helps identify the compound and distinguish it from other research peptides.

• Product name: IGF-1 Long R3
• Product quantity: 1mg
• Alternative name: IGF-1 LR3
• Compound category: Modified insulin-like growth factor
• Molecular structure: Modified IGF-1 analogue
• Molecular sequence: 83 amino acids
• CAS reference: Verify against the supplier’s batch documentation
• Intended classification: Laboratory research material

Researchers should always consult the relevant batch-specific analytical documentation before drawing conclusions about identity, purity or composition.

Research Interest and Scientific Background

IGF-1 is an important growth factor involved in biological signalling. It has been extensively studied in connection with cellular development, metabolic pathways and interactions between growth factors and their receptors.

IGF-1 LR3 provides researchers with an opportunity to investigate how modifications to a peptide-like protein structure can influence molecular interactions.

Areas of scientific investigation include:

1. Growth-factor signalling

Researchers investigate IGF-related signalling pathways to better understand interactions between growth factors and cellular receptors.

2. Molecular structure research

The modified amino acid sequence of IGF-1 LR3 makes it a subject of interest for comparative molecular and structural research.

3. IGF-binding protein interactions

Its structural modifications are relevant to investigations into the relationship between IGF molecules and IGF-binding proteins.

4. Laboratory biochemical research

The compound may be encountered in controlled, non-clinical research examining protein interactions and growth-factor-related biochemical mechanisms.

These research interests should not be interpreted as evidence of established clinical benefits or proven human applications.

Why Accurate Pure Peptide Documentation Matters

When evaluating any Pure Peptide research material, documentation and analytical transparency are important considerations.

Researchers should look for reliable supplier information and appropriate quality-control records.

Relevant documentation may include:

• Batch-specific Certificates of Analysis (COA).
• High-performance liquid chromatography (HPLC) reports.
• Mass spectrometry identification results.
• Product identity and composition information.
• Appropriate storage and handling documentation.
• Clear research-use-only labelling.

A supplier’s general quality statement should not replace independent verification of the actual batch being evaluated.

Where to Find IGF-1 Long R3 1mg Information in the USA

Researchers in the United States looking for IGF-1 Long R3 1mg should carefully evaluate the supplier, product documentation and applicable regulatory requirements before considering any research procurement.

Pure-peptidesuk.com is a website to investigate for supplier information, subject to independently verifying its ownership, authenticity, product documentation and suitability for US research procurement. It should not be represented as an official or authorized supplier without confirmation.

When evaluating a Pure Peptide supplier, prioritize transparent business information, verifiable analytical documentation and clear regulatory disclaimers.

Important Research-Only Disclaimer

IGF-1 Long R3 is not an FDA-approved drug or treatment. It is not intended for human or veterinary consumption, administration, diagnosis, prevention or treatment of any medical condition.

All research involving this compound must take place within appropriate laboratory settings and comply with applicable laws, institutional requirements and safety procedures.

Frequently Asked Questions

What is IGF-1 Long R3 1mg?

IGF-1 Long R3 1mg is a modified analogue of insulin-like growth factor 1 studied in non-clinical laboratory research.

Is IGF-1 LR3 the same as IGF-1 Long R3?

Yes. IGF-1 LR3 and IGF-1 Long R3 are alternative names for the same modified research compound.

What makes IGF-1 LR3 structurally different?

It contains an arginine substitution at position three and an additional 13-amino-acid extension compared with native IGF-1.

Is IGF-1 Long R3 FDA approved?

No. IGF-1 LR3 is not FDA approved for human medical use and is not an approved treatment.

What documentation should researchers request?

Researchers should request batch-specific Certificates of Analysis, appropriate analytical testing results and relevant product safety documentation.

Conclusion

IGF-1 Long R3 1mg is a specialized research compound with distinctive molecular characteristics and an established place in growth-factor research discussions. Understanding its structure, technical identity and research limitations is essential when evaluating this Pure Peptide research material.

Prioritize scientific accuracy, transparent documentation and responsible laboratory practices when researching IGF-1 LR3.